Volume Alert - HCA 65.23 Hca Holdings Inc. Common Stock

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2014 at 12:33 PM

Volume Alert - HCA 65.23 Hca Holdings Inc. Common Stock $HCA Hit a high today of 65.41 Closing the day 10:30 at 65.23 -0.78 -1.18% With a day low of 63.76 and a total volume of 1,938,768.

HCA Recent Posts: http://investorshangout.com/Hca-Holdings-Inc-...HCA-51255/

HCA Hca Holdings Inc. Common Stock Recent Headline News

HCA Holdings (HCA) Stock Lower in Pre-Market Trading Today After Ratings Downgrade
at The Street - Wed Nov 12, 8:23AM CST
HCA Holdings (HCA) stock is declining in pre-market trading following a ratings downgrade to 'market perform' from 'outperform' at Wells Fargo.
HCA: 65.19 (-0.82)

HCA to Present at November and December Healthcare Conferences
Business Wire - Tue Nov 11, 4:43PM CST
HCA Holdings, Inc. (NYSE: HCA) will present at the following healthcare conferences in November and December 2014.
HCA: 65.19 (-0.82)

Could This Supreme Court Ruling Unravel Obamacare?
Sean Williams, The Motley Fool - Motley Fool - Tue Nov 11, 8:12AM CST
Source: White House on Flickr. Even though the Patient Protection and Affordable Care Act, which most Americans known better as Obamacare, was signed into law more than four years ago and has been fully implemented on the individual side of the...
CNC: 96.32 (+1.16), HCA: 65.19 (-0.82), ACN: 84.10 (+0.16), WLP: 127.29 (+0.67)

Stock Movers: Why These 5 Top Stocks Are Rising Today
at Investor's Business Daily - Mon Nov 10, 1:04PM CST
Here is why shares of biotech Gilead Sciences (GILD) and three four other highly rated stocks are rallying in heavy volume today. Gilead began running up in premarket trading after drug giant Merck (MRK) said Sunday it would not move forward with...
DHI: 24.16 (+0.21), AMBA: 49.93 (+0.74), GPRO: 77.20 (+2.20), HCA: 65.19 (-0.82), LEN: 45.61 (-0.78), YY: 79.81 (+0.03), GILD: 106.97 (-1.04), CYH: 47.17 (-1.49), MRK: 59.31 (-0.06), TASR: 19.62 (+0.11), TOL: 33.76 (+0.04), DGLY: 12.60 (+0.12)

Healthcare Stocks Hit on Obamacare Challenge - Analyst Blog
Swarup Gupta - Zacks Investment Research - Mon Nov 10, 10:32AM CST
The Supreme Court has agreed to hear a case challenging the subsidies made available by the Affordable Care Act (ACA).
HCA: 65.19 (-0.82), THC: 47.79 (-0.48), CYH: 47.17 (-1.49), UNH: 95.79 (+0.10), AET: 84.60 (+0.10), WLP: 127.29 (+0.67), XLV: 67.93 (-0.03)

Health Care Facilities Stocks Review - HCA Holdings, Tenet Healthcare, Community Health Systems, Universal Health Services, and VCA Inc.
PR Newswire - Mon Nov 10, 7:35AM CST
Investor-Edge has initiated coverage on the following equities: HCA Holdings Inc. (NYSE: HCA), Tenet Healthcare Corporation (NYSE: THC), Community Health Systems Inc. (NYSE: CYH), Universal Health Services Inc. (NYSE: UHS), and VCA Inc. (NASDAQ: WOOF). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, November 07, 2014, the NASDAQ Composite ended at 4,632.53, down 0.13%, the Dow Jones Industrial Average advanced 0.11%, to finish the day at 17,573.93, and the S&P 500 closed at 2,031.92, up 0.03%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 775.27, down 0.94%, while the index has advanced 10.75% in the previous three months. Register for your complimentary reports on these five stocks at:
HCA: 65.19 (-0.82), THC: 47.79 (-0.48), UHS: 98.06 (-0.76), CYH: 47.17 (-1.49), WOOF: 46.27 (+0.04)

Ride The Smart-Money Coattails: Use IBD's Funds Pages
at Investor's Business Daily - Fri Nov 07, 3:10PM CST
Selecting stocks that have superior profit and sales growth is not the sole key to success in the market. Neither is simply buying stocks with outstanding price strength. Before you invest in a stock, make sure that it also is a favorite among the...
AGN: 196.62 (+1.28), HCA: 65.19 (-0.82), BIDU: 248.95 (-1.39), ZBRA: 72.35 (+0.08), SWKS: 61.30 (+0.33), ALK: 55.69 (-0.45), CELG: 107.60 (-0.25)

Time to Sell These 5 'Toxic' Stocks: AstraZeneca, DigitalGlobe and More
at The Street - Fri Nov 07, 2:49PM CST
Guess what? Stock selection matters more than ever in 2014.
HCA: 65.19 (-0.82), TLK: 44.50 (+0.16), FITB: 20.25 (+0.01), DGI: 28.31 (+0.02), AZN: 74.28 (+0.08)

3 Growing Hospitals For A Crazy Market
Zacks Investment Research - Seeking Alpha - Fri Nov 07, 11:30AM CST
Markets have been rocky lately, with the S&P 500 index making a roughly 200 point round trip over the last three months. Worries about international growth in the wake of soft headlines out of Germany and elsewhere in Europe and never ending...
ACHC: 60.85 (-0.63), HCA: 65.19 (-0.82), LPNT: 64.48 (-1.46)

Collaboration, Breakthrough Therapy Designation, Clinical Trial Data, Voting Rights, and Financial Results - Research Reports on Johnson & Johnson, Merck, Amgen, Shire and HCA
PR Newswire - Fri Nov 07, 7:50AM CST
Today, Analysts Review released its research reports regarding Johnson & Johnson (NYSE: JNJ), Merck & Co., Inc. (NYSE: MRK), Amgen, Inc. (NASDAQ: AMGN), Shire PLC (NASDAQ: SHPG) and HCA Holdings Inc. (NYSE: HCA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7775-100free.
HCA: 65.19 (-0.82), JNJ: 108.88 (-0.03), PCYC: 138.80 (+4.51), SHPG: 200.21 (-2.00), MRK: 59.31 (-0.06), AMGN: 162.86 (+0.44)

Hugh C. Tappan Appointed President of HCA's South Atlantic Division
Business Wire - Thu Nov 06, 12:00PM CST
HCA (NYSE:HCA) today announced the appointment of Hugh Tappan as President of HCA's South Atlantic Division effective January 1, 2015. Tappan replaces Jamie Thomas who recently announced his retirement.
HCA: 65.19 (-0.82)

3 Growing Hospitals for a Crazy Market - Investment Ideas
Brian Hamilton - Zacks Investment Research - Thu Nov 06, 8:12AM CST
3 Growing Hospitals for a Crazy Market - Investment Ideas
ACHC: 60.85 (-0.63), HCA: 65.19 (-0.82), LPNT: 64.48 (-1.46)

Acadia Healthcare Company (ACHC) Rises: Stock Up 5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:32AM CST
Acadia Healthcare Company, Inc. (ACHC) was a big mover last session, as the company saw its shares rise more than 5% on the day.
ACHC: 60.85 (-0.63), HCA: 65.19 (-0.82), CYH: 47.17 (-1.49), ADPT: 32.93 (+0.08)

3 Ways You Can Profit from Obamacare
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 01, 1:01PM CDT
Source: Centene Corp. The Affordable Care Act's second open enrollment period begins on Nov. 15 and expectations are that millions more Americans will use the federal and state exchanges to sign up for health insurance to avoid the health...
CNC: 96.32 (+1.16), HCA: 65.19 (-0.82), WLP: 127.29 (+0.67)

41 Billionaires: Meet the Richest Person in Every U.S. State
at The Street - Sat Nov 01, 9:11AM CDT
No matter where you live, there's someone living nearby who is richer than you are -- unless you're on this new list out from Wealth-X.
CLR: 54.94 (+0.02), CCL: 40.43 (-0.20), NKE: 95.59 (+0.71), GMCR: 153.97 (-0.72), WMT: 79.37 (+0.36), LVS: 61.81 (+0.10), ORCL: 40.50 (+0.03), DISH: 63.84 (+0.05), HUN: 24.76 (-0.43), HCA: 65.19 (-0.82), LB: 77.87 (+1.17), BRK.B: 145.49 (+0.54), MSFT: 48.86 (-0.01)

HCA Holdings Picks Prime Sites For Its Hospitals
at Investor's Business Daily - Fri Oct 31, 4:00PM CDT
If you're going to own hospitals, location matters. Serving areas with a growing population can lead to heavier usage and higher profits. Take HCA Holdings (HCA), the largest operator of acute care hospitals in the U.S. It owns roughly 160 hospitals...
HCA: 65.19 (-0.82)

Time to Buy This Top Hospital Stock?
Todd Campbell, The Motley Fool - Motley Fool - Thu Oct 30, 10:00AM CDT
Source: HCA Holdings via Google Maps Hospitals have taken their fair share of hard knocks in the past. Bloated administrative costs, flagging demand for elective surgery, and payer push-back on prices have all weighed down industry profitability....
HCA: 65.20 (-0.81)

Merger Agreement, Tender Offer Commencement, Contracts, Leadership Changes, and Market Activity - Research Reports on Encana, PPG, Williams Partners, Ecolab and HCA
PR Newswire - Thu Oct 30, 8:00AM CDT
Today, Analysts Review released its research reports regarding Encana Corporation (NYSE: ECA), PPG Industries Inc. (NYSE: PPG), Williams Partners L.P (NYSE: WPZ), Ecolab Inc. (NYSE: ECL) and HCA Holdings, Inc. (NASDAQ: HCA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7564-100free.
HCA: 65.20 (-0.81), ATHL: 58.43 (+0.02), ECA: 18.58 (+0.11), PPG: 203.31 (-1.95), WPZ: 51.35 (-0.34), ECL: 112.71 (-0.08)

HCA Holdings (HCA) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Wed Oct 29, 6:43PM CDT
The following HCA Holdings (HCA) conference call took place on October 28, 2014, 10:00 AM ET. This is a transcript of that earnings call:
HCA: 65.21 (-0.80)

Hca Holdings Inc. Common Stock (HCA) Stock Research Links

HCA Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....